NCCMH E-bulletin - Vol 10 Iss 4 (Nov - Dec 2011)

The NCCMH's e-bulletin contains Internet links to the latest mental health news, including clinical news, health and social care guidance, publications and policy. Read the latest news below or use the news archive to find news items from the past. Issues of our e-bulletin are published every two months.

To get the e-bulletin delivered by E-mail, click here. To unsubscribe, please send a message to admin@nccmh.org.uk with the subject heading 'Unsubscribe NCCMH E-bulletin'.

November - December 2011. The next issue of this bulletin will be published in early March.
NCCMH Induced Abortion and Mental Health: A systematic review of the evidence - full report and consultation table with responses New guidance and quality standard published on service user experience in adult mental health New guidance published for the longer-term management of self-harm
Audit Commission Joining up health and social care: Improving value for money across the interface –briefing NHS quality accounts 2010/11 – report
British Medical Association Admissions rise reveals alcohol crisis BMA Council opposes plans to 'privatise' commissioning support BMA defends public health spending pot BMA helps fund public health institute BMA makes case for health impact assessments BMA response to survey of public health experts on NHS reform Doctors go on camera with fears for patient care Doctors 'vital' for success of healthcare reforms Doctors welcome launch of research ‘champion’ GPs spell out essential commissioning concessions Guarantee sought for service integration Health and Social Care Bill continues to cause chaos in the NHS, says BMA – briefing Lansley seeks to provide commissioning reassurances New government proposals would give large commercial companies in-built advantage in new commissioning structures, warns BMA NHS chief downplays GP fears of plans to 'privatise' commissioning support Psychiatrists welcome ‘tax on work’ U-turn Self-care scheme launched Survey reveals reforms anger Vision for evolution of the NHS shared
Canadian Agency for Drugs and Technologies in Health (CADTH) CADTH optimal use review: Combination and high doses atypical antipsychotics for schizophrenia CADTH Rapid Review: Guidelines and recommendations on the admission and treatment of patients with anorexia
Care Quality Commission Care Quality Commission response to the National Audit Office report CQC publishes first reports from its review of services for people with learning disabilities – report CQC to target home care services Our second Mental Health Act annual report 2010/11 – report
Centre for Mental Health A new centre for health and justice Centre for Mental Health welcomes focus on mental health in new NHS Operating Framework Centre supports Mental Health Discrimination Board Centre welcomes report by Mind following an inquiry into acute and crisis mental healthcare in the UK Housing instability is linked to poor mental health and offending, says Centre for Mental Health – briefing paper Mental health organisations welcome announcement of depression incentives for GPs Mental Health teams in hospitals can achieve major cost savings to the NHS, finds new report – report Prospective observational study shows employment linked to better outcomes for people with schizophrenia
Cochrane Collaboration New systematic reviews: Home-based child development interventions for preschool children from socially disadvantaged families Interventions for treating anxiety after stroke Mirtazapine versus other antidepressive agents for depression Naftidrofuryl for dementia Oxcarbazepine for acute affective episodes in bipolar disorder Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years Second-generation antidepressants for seasonal affective disorder Social skills training for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years Updated reviews: Auditory integration training and other sound therapies for autism spectrum disorders (ASD) Day hospital versus admission for acute psychiatric disorders Music therapy for people with schizophrenia and schizophrenia-like disorders Psychological and educational interventions for preventing depression in children and adolescents Tiagabine in the maintenance treatment of bipolar disorder
Department of health (DoH) Accelerating adoption of innovation in the NHS – report Andrew Lansley takes firm action to protect patient choice Atlas maps out variation in NHS Children and Young People’s Mental Health – recent developments – letter Creation of the Health Research Authority Department of Health response to the CCP’s report on patient choice GP practice data available to patients and professionals Guidance and toolkit for vulnerable adult interventions Guidance published for technology enhanced learning Health Survey for England released JSNAs and joint health and wellbeing strategies explained – document Mental Health PbR Quality and Outcomes Indicators Report New Approaches to Supporting Carers’ Health and Well-being – report New institute to help narrow the health gap New NHS operating framework published New start date and more funding announced for local HealthWatch bodies New toolkit launched to promote equality and fairness in the NHS NHS Information Centre data on abuse of vulnerable adults NHS on track to deliver savings to reinvest in care NHS Outcomes Framework – renewed focus on improving patient results Protecting and Promoting Patients Interests: the role of Sector Regulation – briefing document Public health reform updates published Results of GP patient survey Six out of ten people with dementia go undiagnosed – £2 million campaign launched to tackle dementia Statistical press notice: Mental Health Community Teams Activity data, 2011-12 Q2 Substance misuse services in adult prisons in England – letter Technical guidance for the 2012/13 Operating Framework The Adult Social Care Outcomes Framework: Handbook of definitions
European Medicines Agency (EMEA) CHMP revised EPARs started on: Axura, Memantine, Revision:16, Authorised Ebixa, Memantine, Revision: 19, Authorised Exelon, Rivastigmine, Revision: 24, Authorised Invega, Paliperidone, Revision: 7, Authorised Lyrica, Pregablin, Revision: 17, Authorised Nimvastid, Rivastigmine, Revision: 3, Authorised Rivastigmine 1 A Pharma, Rivastigmine, Revision: 2, Authorised Rivastigmine Hexal, Rivastigmine, Revision: 2, Authorised Rivastigmine Sandoz, Rivastigmine, Revision: 2, Authorised Rivastigmine Teva, Rivastigmine, Revision: 4, Authorised Sycrest, Asenapine, Revision: 3, Authorised Xeplion, Paliperidone, Revision: 2, Authorised Zypadhera, Olanzapine, Revision: 4, Authorised Zyprexa Velotab, Olanzapine, Revision: 19, Authorised Zyprexa, Olanzapine, Revision: 26, Authorised Pending EC decision: Ariclaim, Duloxetine Cymbalta, Duloxetine Xeristar, Duloxetine Opinion/Decision on: Paediatric Investigation Plan (PIP): -, (1R, 4S, 5S, 6S)-4-[[(2s)-2-amino-4-(methylthio)-1-oxobutyl]amino]-2-thiabicyclo[3.1.0]hexane-4,6-dicarboxylic acid,2,2-dioxide, monohydrate (LY2140023) Paediatric Investigation Plan (PIP): -, 1-[2-(2,4-Dimethyl-phenylsulfanyl)phenyl]piperazine (Lu AA21004) News: European Medicines Agency formalises interaction with healthcare professionals
Food and Drug Administration (FDA) Approvals: Bupropion hydrochloride (nda # 022497) Intelgenx Corp Methylphenidate hydrochloride (anda # 078458) Actavis Risperidone (anda # 077493) Prinston Inc Risperidone (anda # 090839) Jubilant Organosys Zolpidem tartrate (nda # 022328) Transcept Pharms Tentative Approvals: Duloxetine hydrochloride (anda # 090694) Lupin Pharms Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in adults Selective serotonin reuptake inhibitor (SSRI) antidepressant use during pregnancy and reports of a rare heart and lung condition in newborn babies
Joseph Rowntree Foundation (JRF) A Better Life - what older people with high support needs value – report Involving older people in service commissioning: more power to their elbow? – report Rethinking disability policy – report
Kings Fund Health regulator may fail unless health bill is amended, says new report from The King's Fund – report Improving health and health care in London: Who will take the lead? – report Integrated care for patients and populations: Improving outcomes by working together – report The King's Fund comments on the publication of the NHS Outcomes Framework for 2012/13
Medicines and Healthcare products Regulatory Agency (MHRA) Information sent to healthcare professionals in December about the safety of medicines: Strattera (atomoxetine), Cipralex (escitalopram), Seroquel (quietapine) Reducing medicines risk - Learning package on selective serotonin reuptake inhibitors
Mental Health Foundation (MHF) Annual Review 2011 – report Mental Health Foundation welcomes new data on the use of specialist mental health services
MIND Challenge to discriminatory mental health law Government to look again at changes to after care services Listening to experience - report Mental health emergency treatment inaccessible and ineffective, say patients – inquiry Mental health still a taboo in the media, new research shows – survey Mind fears for those treading the poverty line – survey Mind responds to latest talking therapy figures Time to Change Wales: a briefing
National electronic Library for Medicines (NeLM) Association between patient beliefs regarding assigned treatment and clinical response: reanalysis of data from the Hypericum Depression Trial Study Group Cohort study finds no increased risk of serious adverse cardiovascular events in adults treated with ADHD medications Cohort study: Antipsychotic use among children may increase risk of diabetes? Extent of illicit drug use and dependence, and their contribution to the global burden of disease Horizon scanning: Licensing application submitted in EU for nalmefene (Selincro™) for treatment of alcohol dependence Horizon scanning: MHRA to review marketing authorisation application for lisdexamfetamine for ADHD How should depression be treated in a patient with Parkinson’s disease? Lancet seminar: Major depressive disorder New long-term data on extended-release naltrexone injection (Vivitrol®) for opioid dependence disorder NHS Evidence expert commentary: Treating depression in people with dementia Over-the-counter codeine analgesic misuse and harm: characteristics of cases in Australia and New Zealand Psychotropic medication burden and factors associated with antipsychotic use: an analysis of a population-based sample of community-dwelling older persons with dementia RADAR review: Asenapine for schizophrenia or bipolar I disorder (acute mania or maintenance) RCT: Budget impact and sustainability of medical care management for persons with serious mental illnesses RCT: Risperidone, lithium, or divalproex sodium for bipolar I disorder, manic or mixed phase, in children and adolescents RCT: Study of adjunctive counselling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence Reasons for continuing or discontinuing olanzapine in the treatment of schizophrenia from the perspectives of patients and clinicians Schizophrenia medication adherence in a resource-poor setting: randomised controlled trial of supervised treatment in out-patients for schizophrenia (STOPS) Severity of depression and response to antidepressants: GENPOD randomised controlled trial Stimulant use and stimulant use disorders in Australia: findings from the National Survey of Mental Health and Wellbeing The guideline on 'Harmful use and dependence of prescribed drugs' in routine medical care. A study among participants in a continuing development course on 'Addiction medicine in primary care' Trends in use of second-generation antipsychotics for treatment of bipolar disorder in the United States, 1998-2009 Updated meta-analysis: No clinically significant difference in efficacy between the second-generation antidepressants? Violence among persons diagnosed with schizophrenia: how pharmacists can help
National Institute for Health and Clinical Excellence (NICE) New NICE guidance for the longer-term management of self-harm NICE consults on draft recommendations on recognising autism in adults NICE launches consultation on 2013/14 QOF [closes 6 February 2012] NICE publishes new quality standard and guidance on service user experience in mental health
National Institute for Health Research (NIHR) Treating sleep problems may be important in schizophrenia
National Prescribing Centre (NPC) A comparison of the effectiveness of antimanic drugs in acute mania – MeRec Rapid Review
National Treatment Agency for Substance Misuse Delivering a consensus on hepatitis C, substance misuse and health inequalities Substance misuse among young people 2010-11 – report
NHS Choices Autism 'may develop in the womb' Can eating fish prevent Alzheimer's? Childhood IQ 'linked to adult drug use' Do our brains decline from middle age? Does brain size predict Alzheimer's? Electrical Alzheimer's therapy tested Learn dementia signs, public urged Rare syndrome 'may give autism clues' Study looks at self-harm in young people
NHS Confederation 2012/13 Operating Framework - full briefing for members Challenges for 2012: Letting go of "hospital-or-bust" model of care Developing an outcomes-based approach in mental health – report Government needs to minimise health reform risks for children and child health – report Housing and mental health – briefing Integrating services shown to increase quality and generate savings Integration will be good for patients but requires social care reform first Involving children and young people in health services – report New service models in mental health: emerging lessons – digest NHS Confederation part of call for political leadership on social care NHS Future Forum public health and integration reports welcomed Payment by Results in mental health – briefing Preventing suicide through community and emergency healthcare – briefing Report reveals significant challenges for mental health tariff – report Social media and mental health services – briefing The search for low-cost integrated healthcare – report
NHS Information Centre Abuse of Vulnerable Adults in England, 2010-11 Provisional, Experimental Statistics Bi-annual analysis of Mental Capacity Act 2005, Deprivation of Liberty Safeguards Assessments (England): April-September 2011 Community Care Statistics: Social Services Activity, England - 2010-11 - Provisional Release Improving Access to Psychological Therapies Key Performance Indicators (IAPT KPIs) Q1 2011/12 final and Q2 2011/12 provisional Mental Health Bulletin - Fifth report from Mental Health Minimum Dataset (MHMDS) annual returns, 2011 Personal Social Services Adult Social Care Survey, England - Final 2010-11 Personal Social Services Expenditure and Unit Costs: 2010-11, provisional release Routine Quarterly Mental Health Minimum Dataset Reports Provisional Q1 2011/12 summary statistics and related information Statistics on Drug Misuse: England, 2011 Survey of Carers in Households - 2009/10 England
Office for National Statistics Scotland: Estimating the National and Local Prevalence of Problem Drug Misuse in Scotland - 2009/10 Mental Health (Psychiatric) Hospital Activity Statistics - Year Ending 31 March 2011 Scottish Schools Adolescent Lifestyle and Substance Use Survey - 2010 National and Local Reports - December 2011 Release Scottish Suicide Information Database - Report 2011 Wales: Substance Misuse in Wales - April-June 2011
Prodigy Alcohol - problem drinking – guidance (updated to reflect recommendations in the clinical guideline Alcohol-use disorders: diagnosis, assessment and management of harmful drinking and alcohol dependence from the National Institute for Health and Clinical Excellence [NICE, 2011b]. Opioid dependence – guidance (minor update to include relevant recommendations from the NICE guideline Needle and syringe programmes: providing people who inject drugs with injecting equipment [NICE, 2009].
Rethink Charity launches independent commission on schizophrenia to mark 100 years of forgotten illness It’s time to review over-use of draconian powers which deprive rights of mentally ill, says charity Nine out of ten people in UK believe at least one myth about schizophrenia - survey
Royal College of General Practitioners (RCGP) RCGP launches e-learning course on self care
Royal College of Physicians (RCP) Future Forum interim advice - RCP positions on integration and information NHS missing key opportunities to tackle alcohol abuse – report RCP comment on NHS Outcomes Framework
Royal College of Psychiatrists (RCPsych) Significant improvements needed to care for people with dementia in hospital, says national clinical audit – report The management of substance misuse detainees in police custody: updated guidelines Therapy demonstrates patient benefits but improvement needed, audit finds - report
Royal Pharmaceutical Society of Great Britain (RPSGB) Introducing Medicines for children website Involving patients in decision-making about their medicines – report
Scottish Medicines Consortium (SMC) SMC recommends paliperidone palmitate (Xeplion) for maintenance treatment of schizophrenia in adult patients stabilised with paliperidone or risperidone
Social Care Institute for Excellence (SCIE) Judging cost effectiveness - Economic evaluation in social care Parental mental health guide updated Safeguarding adults at risk of harm: A legal guide for practitioners – report SCIE and the Mental Capacity Act 2005 Sexual health elearning - new resources for mental health professionals
The next issue of our bulletin is due to be published in early March